Citius Oncology, Inc. (CTOR) financials · $105.2M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Citius Oncology, Inc. (CTOR) $105.2M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$23.5M | -$20.6M |
| Net Income | -$24.8M | -$21.1M |
| EPS (Diluted) | -$0.34 | -$0.31 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $100.9M | $84.4M |
| Current Assets | $27.5M | $11.0M |
| Cash & Equivalents | $3.92M | N/A |
| Inventory | $22.3M | $8.27M |
| Total Liabilities | $56.1M | $38.2M |
| Current Liabilities | $49.5M | $32.7M |
| Shareholders' Equity | $44.9M | $46.1M |
| Retained Earnings | -$64.0M | -$39.3M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$5.49M | $126.4K |
| Investing Cash Flow | -$5.75M | -$5.00M |
| Financing Cash Flow | $15.2M | $4.87M |
FAQ
What is CTOR P/E and revenue?
Citius Oncology, Inc. (CTOR) $105.2M cap.
What is CTOR revenue?
CTOR income-statement cache has no revenue figure yet.
Is CTOR profitable?
Citius Oncology, Inc. last cached net income is -$24.8M (FY2025).
What are CTOR total assets?
Citius Oncology, Inc. last cached total assets are $100.9M (FY2025).
What is CTOR free cash flow?
No cached cash-flow row for CTOR yet.
Not investment advice. Cached statements, not a live tape.